Home > Press > Nano Chemical Systems Holdings, Inc. Announces Investor Conference Call Hosted by Management
Nano Chemical Systems Holdings, Inc., (OTC Bulletin Board: NCSH) announces it will host an
investor conference call on Tuesday, January 23, 2007, to begin at 4:15 P.M. Eastern Time.
Nano Chemical Systems Holdings, Inc. Announces Investor Conference Call Hosted by Management
SEAFORD, Del. | Posted on January 16th, 2007
In discussing the conference call, Dr. Mathew Zuckerman, CEO of Nano Chemical stated, "We have a commitment to our shareholders as well as the investment community for high level disclosure and communication, and for that reason we are looking forward to discussing our progress and developments with our shareholders and the investment community."
Interested parties may hear and participate in the call by telephone.
Instructions for the call are:
To hear the conference call as it takes place:
Call 800-391-2548 in the United States or;
Call 866-627-1646 in Canada or;
Call 302-709-8328 Internationally
Verbal Pass code: VT78684
To hear a recording of the call (available for 30 days following the
Call 800-355-2355 in the United States;
Call 402-220-2946 in Canada or Internationally
Pin Code: 78684
About Nano Chemical Systems Holdings, Inc.
Nano Chemical Systems Holdings, Inc. operates two wholly owned subsidiaries: SeaSpray Aerosol, Inc. which produces aerosol and liquidfilled products for its own product line and private labeling for various customers in a 36,000 square foot facility, and Nano Chemical Systems Inc., which is engaged in nanotechnology research and development to enhance its own application specific product line for targeted market applications.
Certain statements in this release and other written or oral statements made by or on behalf of the Company are "forward-looking statements" within the meaning of the federal securities laws. Statements regarding future events and developments and our future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future are forward-looking statements within the meaning of these laws. The forward- looking statements are subject to a number of risks and uncertainties including market acceptance of the Company's services and projects and the Company's continued access to capital and other risks and uncertainties outlined in its filings with the Securities and Exchange Commission, which are incorporated herein by reference. The actual results the Company achieves may differ materially from any forward-looking statements due to such risks and uncertainties. These statements are based on our current expectations and speak only as of the date of such statements. The Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of future events, new information or otherwise.
For more information, please click here
INVESTOR CONTACT: Redwood Consultants, LLC - 415-884-0348
Copyright © PR Newswire Association LLC.
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014
Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014
Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014
'Exotic' material is like a switch when super thin April 18th, 2014
Innovative strategy to facilitate organ repair April 18th, 2014
INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014
'Life Redesigned: The Emergence of Synthetic Biology' Lecture at Brookhaven Lab on Wednesday, April 30: Biomedical Engineer James Collins to Speak for BSA Distinguished Lecture Series April 16th, 2014
ECHA Planning Workshop on Regulatory Challenges in the Risk Assessment of Nanomaterials April 16th, 2014
Engineers develop new materials for hydrogen storage April 15th, 2014